Creative Medical Technology Holdings, Inc. (CELZ)
NASDAQ: CELZ · Real-Time Price · USD
2.290
+0.060 (2.69%)
At close: May 7, 2026, 4:00 PM EDT
2.310
+0.020 (0.88%)
Pre-market: May 8, 2026, 7:01 AM EDT

CELZ Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
8746514
Market Cap Growth
148.98%79.39%-36.22%18.07%-61.72%-34.43%
Enterprise Value
1.270.06-1.89-3.64-13.023.3
Last Close Price
2.291.962.314.613.8122.10
PE Ratio
--0.78-0.62-1.23-0.410.39
PS Ratio
1410.901207.58367.17703.6060.53159.64
PB Ratio
1.130.960.640.610.341.37
P/TBV Ratio
0.750.620.540.630.260.70
P/FCF Ratio
--1.24-0.76-0.79-0.69-6.32
P/OCF Ratio
--1.24-0.76-0.79-0.69-6.32
EV/Sales Ratio
211.9110.26-171.58-404.49-146.9737.60
EV/EBITDA Ratio
--0.010.340.661.28-1.09
EV/EBIT Ratio
--0.010.330.651.27-1.06
EV/FCF Ratio
--0.010.360.451.67-1.49
Debt / Equity Ratio
0.000.000.000.000.000.00
Debt / EBITDA Ratio
0.000.000.000.000.000.00
Debt / FCF Ratio
0.000.000.000.000.00-0.01
Net Debt / Equity Ratio
-0.96-0.96-0.93-0.96-1.16-1.05
Net Debt / EBITDA Ratio
1.201.201.051.811.813.53
Net Debt / FCF Ratio
1.231.231.121.242.364.83
Asset Turnover
0.000.000.000.000.010.01
Inventory Turnover
2.002.001.000.432.718.83
Quick Ratio
25.4925.4918.1326.895.5410.21
Current Ratio
25.9725.9718.7327.665.6410.22
Return on Equity (ROE)
-86.47%-86.47%-65.85%-40.34%-77.78%-129.87%
Return on Assets (ROA)
-84.85%-84.85%-66.08%-37.59%-67.28%-52.16%
Return on Invested Capital (ROIC)
-1646.86%-1646.86%-1461.13%522.96%680.19%734.11%
Return on Capital Employed (ROCE)
-88.60%-88.60%-68.85%-42.89%-78.55%21.13%
Earnings Yield
-70.82%-128.57%-160.61%-81.56%-243.57%253.85%
FCF Yield
--80.83%-131.26%-126.77%-145.38%-15.82%
Buyback Yield / Dilution
-60.95%-60.95%-5.17%-28.76%-236.51%-460.63%
Total Shareholder Return
-60.95%-60.95%-5.17%-28.76%-236.51%-460.63%
Updated Mar 20, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q